Inventor · disambiguated record
Lior Izhar
Also filed as: IZHAR LIOR
14 granted patents·28 pending applications·5 citations·filing 2017–2025
85Inventor score
Top patents by PatentIndex Score
42 records- 0185US11666641B2CRISPR nucleaseEMENDOBIO INC·Filed 2020·Granted Jun 6, 2023·2 cites·39 claims
- 0284US11827879B2Differential knockout of an allele of a heterozygous bestrophin 1 geneEMENDOBIO INC·Filed 2018·Granted Nov 28, 2023·3 cites·11 claims
- 0376US2025057988A1Guide RNA That Targets A Mutant Human Guanylate Cyclase 2A AlleleEMENDOBIO INC·Filed 2024·Application pending·0 cites
- 0474US2024229024A9Compositions for genome editingEMENDOBIO INC·Filed 2023·Application pending·0 cites
- 0573US2024132881A1Differential knockout of an allele of a heterozygous bestrophin 1 geneEMENDOBIO INC·Filed 2023·Application pending·0 cites
- 0672US2024384306A1Compositions And Methods For Promoting Gene Editing of CXCR4 GeneEMENDOBIO INC·Filed 2024·Application pending·0 cites
- 0769US2025197822A1Novel omni-59, 61, 67, 76, 79, 80, 81 and 82 crispr nucleasesEMENDOBIO INC·Filed 2024·Application pending·0 cites
- 0868US2024226246A9Novel omni-50 crispr nucleaseEMENDOBIO INC·Filed 2023·Application pending·0 cites
- 0965US12480140B2Differential knockout of an allele of a heterozygous ELANE geneEMENDOBIO INC·Filed 2019·Granted Nov 25, 2025·0 cites·12 claims
- 1064US12435334B2Differential knockout of an allele of a heterozygous ELANE gene-IIEMENDOBIO INC·Filed 2020·Granted Oct 7, 2025·0 cites·7 claims
- 1164US11946077B2OMNI-59, 61, 67, 76, 79, 80, 81, and 82 CRISPR nucleasesEMENDOBIO INC·Filed 2021·Granted Apr 2, 2024·0 cites·21 claims
- 1263US12359196B2Differential knockout of an allele of a heterozygous fibrinogen alpha chain (FGA) geneEMENDOBIO INC·Filed 2018·Granted Jul 15, 2025·0 cites·3 claims
- 1361US12168062B2Guide RNA that targets a mutant human guanylate cyclase 2A alleleEMENDOBIO INC·Filed 2018·Granted Dec 17, 2024·0 cites·6 claims
- 1460US12258599B2Method to inactivate a mutant allele of an ELANE geneEMENDOBIO INC·Filed 2020·Granted Mar 25, 2025·0 cites·8 claims
- 1560US2025283115A1Engineered high fidelity omni-50 nuclease variantsEMENDOBIO INC·Filed 2022·Application pending·0 cites
- 1660US2025043260A1Engineered High Activity Omni-79 Nuclease VariantsEMENDOBIO INC·Filed 2022·Application pending·0 cites
- 1760US2025277202A1Knockout of a mutant allele of an elane geneEMENDOBIO INC·Filed 2025·Application pending·0 cites
- 1859US11795453B2Compositions for genome editingEMENDOBIO INC·Filed 2017·Granted Oct 24, 2023·0 cites·19 claims
- 1959US2020123542A1Rna compositions for genome editingEMENDOBIO INC·Filed 2019·Application pending·0 cites
- 2056US12031149B2Compositions and methods for promoting gene editing of CXCR4 geneEMENDOBIO INC·Filed 2020·Granted Jul 9, 2024·0 cites·12 claims
- 2155US12091688B2OMNI-103 CRISPR nucleaseEMENDOBIO INC·Filed 2022·Granted Sep 17, 2024·0 cites·24 claims
- 2255US2025034596A1Omni-103 CRISPR Nuclease-RNA ComplexesEMENDOBIO INC·Filed 2022·Application pending·0 cites
- 2355US2024175013A1Biallelic knockout of tracEMENDOBIO INC·Filed 2021·Application pending·0 cites
- 2454US12274758B2Guide RNA that targets a mutant human inosine monophosphate deyhydrogenase I alleleEMENDOBIO INC·Filed 2018·Granted Apr 15, 2025·0 cites·6 claims
- 2554US2024042025A1Biallelic knockout of b2mIZHAR LIOR·Filed 2021·Application pending·0 cites
- 2652US2023383273A1Novel omni 56, 58, 65, 68, 71, 75, 78, and 84 crispr nucleasesEMENDOBIO INC·Filed 2021·Application pending·0 cites
- 2751US2024376453A1Novel omni 115, 124, 127, 144-149, 159, 218, 237, 248, 251-253 and 259 crispr nucleasesEMENDOBIO INC·Filed 2022·Application pending·0 cites
- 2851US2019330620A1Rna compositions for genome editingEMENDOBIO INC·Filed 2017·Application pending·0 cites
- 2950US2022136013A1Differential knockout of a heterozygous allele of stat1EMENDOBIO INC·Filed 2020·Application pending·0 cites
- 3049US12454705B2Differential knockout of an allele of a heterozygous apolipoprotein A1 (APO1A) geneEMENDOBIO INC·Filed 2019·Granted Oct 28, 2025·0 cites·14 claims
- 3149US2022213456A1Novel omni crispr nucleasesEMENDOBIO INC·Filed 2020·Application pending·0 cites
- 3249US2025011740A1Novel omni 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 and 262 crispr nucleasesEMENDOBIO INC·Filed 2022·Application pending·0 cites
- 3349US2022154157A1New engineered high fidelity cas9EMENDOBIO INC·Filed 2020·Application pending·0 cites
- 3449US2024002840A1Novel omni-50 crispr nuclease-rna complexesIZHAR LIOR·Filed 2021·Application pending·0 cites
- 3548US11274288B2Compositions and methods for promoting homology directed repair mediated gene editingEMENDOBIO INC·Filed 2017·Granted Mar 15, 2022·0 cites·20 claims
- 3648US2024425885A1OMNI 90-99, 101, 104-110, 114, 116, 118-123, 125, 126, 128, 129, and 131-138 CRISPR NUCLEASEEMENDOBIO INC·Filed 2022·Application pending·0 cites
- 3748US2022387515A1Differential knockout of an allele of a heterozygous elane gene using guides 21-30 nucleotides in lengthBARAM DAVID·Filed 2020·Application pending·0 cites
- 3848US2022307057A1Crispr compositions and methods for promoting gene editing of gata2BARAM DAVID·Filed 2020·Application pending·0 cites
- 3948US2022267777A1Differential knockout of a heterozygous allele of rpe65BARAM DAVID·Filed 2020·Application pending·0 cites
- 4047US2022098621A1Crispr compositions and methods for promoting gene editing of ribosomal protein s19 (rps19) geneEMENDOBIO INC·Filed 2020·Application pending·0 cites
- 4146US2022298495A1Novel genome editing toolEMENDOBIO INC·Filed 2020·Application pending·0 cites
- 4242US2023173105A1Differential knockout of an allele of a heterozygous rhodopsin geneEMENDOBIO INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lior Izhar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →